13.10.2022 • NewsBASFcost savings

BASF Plans European Austerity as Outlook Dims

Against the backdrop of weaker than expected third-quarter earnings – “significantly worse” in Europe and a negative result in Germany – as well as deteriorating framework conditions, BASF is launching a cost-saving program focused on those two strategic markets.

The scheme is planned to run from 2023 until the end of 2024, though the German group said initial cost cutting measures will begin immediately, as far as possible.

More than half of the targeted savings is expected to be realized at the Ludwigshafen headquarters site, which is also BASF’s largest and one of the largest chemical sites in Europe.

Over the two-year course, the program is forecast to generate annual cost savings of €500 million in non-production areas. Operating, service and R&D divisions as well as the corporate center are due to be streamlined, the chemical giant said.

© tomertu/Shutterstock
© tomertu/Shutterstock

European production to be “structurally adjusted”

In the medium-to-long term, BASF said it additionally plans to “structurally adjust” its integrated European production network, which it calls “Verbund”. Details are due to be communicated in next year’s first quarter.

Figures for the third quarter show a sales rise of 12% to just under €22 billion, thanks largely to higher selling prices and currency effects, while EBIT before special items crumbled nearly 28% to €1.35 billion as higher energy and raw materials costs could not always be pushed on.

For full year 2022, BASF said the outlook published in July remains unchanged. EBIT before special items is estimated to come in between €6.8 billion and €7.2 billion.

Net income is expected to hover around €909 million. The figure includes impairments for the group’s shareholding in the oil and gas joint venture Wintershall-Dea, which it has had to partially write down.

Author: Dede Williams, Freelance Journalist

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.